Abstract
Embryonic stem (ES) cells are believed to be able to differentiate into all tissues found within the human body. Potentially, these cells could be manipulated in the laboratory to induce the formation of specialised cells and new tissues which could be used to treat diseases such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, heart disease, and kidney failure. The isolation of these cells involves the destruction of a five day old human embryo and is therefore ethically controversial. The aim of this review is to examine the ethical and legal issues raised by ES cell research. Embryonic development and the source of ES cells are described briefly. The ethical implications of ES cell research are presented, with reference to the ongoing debate on the moral status of the embryo. The statutory framework for regulation of embryo research in the UK is described in relation to the Human Fertilisation and Embryology Act, 1990. Finally, the recent amendments to the Human Fertilisation and Embryology Act, 1990 are discussed in light of reports by the Human Genetics Advisory Commission/Human Fertilisation and Embryology Authority, the Nuffield Council on Bioethics, and the Chief Medical Officer's Expert Advisory Group.
Get full access to this article
View all access options for this article.
